Roger Collier | CMAJ | October 12, 2018
  • The widespread sale of cannabis may have unforeseen health consequences for Ontario youth, according to the Association of Local Public Health Agencies. The Ontario organization is recommending that the province’s government limit the number of cannabis retail outlets and set buffer zones around schools.
  • A team at the Hospital for Sick Children in Toronto has written a draft policy on physician-assisted dying for youth aged 18 and over. According to the paper’s authors, it is “intended as a road map through the still-emerging ethical landscape” of medical aid in dying in pediatrics.
  • Alberta, Saskatchewan and Prince Edward Island are the best provinces in which to practise medicine, according to a ranking by The Medical Post. The ranking was based on factors including compensation, work-life balance, medico-legal favourability and professional satisfaction.
  • Saskatchewan residents who received medical assistance in dying will no longer have their deaths classified as suicides. The deaths will now be recorded as unclassified.
  • The Canadian Medical Hall of Fame announced its 2019 inductees. The list includes the late Dr. G. Brock Chisholm, who was “instrumental in the creation of the World Health Organization (WHO), and Connie J. Eaves, a “world authority on stem cells.”
  • The Liberal party of Manitoba has called upon the province’s government to declare a public health emergency to combat a methamphetamine crisis. The province has seen a spike in deaths related to the drug, which has also been linked to a rise in violent crimes.
  • The government of Prince Edward Island has released new diabetes guidelines for schools. The guidelines were created to ensure schools have protocols and teachers are trained to help students with diabetes.
  • Manitoba has set a fine of $672 for people caught smoking or vaping marijuana in public. Residents of Manitoba are prohibited from smoking or vaping non-medical cannabis on streets, sidewalks, parks, beaches, school grounds, restaurant patios and at health care facilities and provincial parks.
  • A drug used to slow the progress of ALS has been approved for sale in Canada by the federal government. The intravenous medication, called edaravone, is already sold in the United States, Japan and South Korea.
  • McGill University tied with the University of Toronto in the medical/doctoral category of Maclean’s annual ranking of universities. Rounding out the top five in the category are the University of British Columbia, McMaster University and Queen’s University.

For more health care news — plus research, analysis, commentary and more — please visit:

CMAJ.CA

Connect with CMAJ

Pin It on Pinterest

Share This